The Clinical Use of Stress Echocardiography in Non-Ischaemic Heart Disease: Recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography




A unique and highly versatile technique, stress echocardiography (SE) is increasingly recognized for its utility in the evaluation of non-ischaemic heart disease. SE allows for simultaneous assessment of myocardial function and haemodynamics under physiological or pharmacological conditions. Due to its diagnostic and prognostic value, SE has become widely implemented to assess various conditions other than ischaemic heart disease. It has thus become essential to establish guidance for its applications and performance in the area of non-ischaemic heart disease. This paper summarizes these recommendations.


Introduction





Attention ASE Members:


The ASE has gone green! Visit www.aseuniversity.org to earn free continuing medical education credit through an online activity related to this article. Certificates are available for immediate access upon successful completion of the activity. Nonmembers will need to join the ASE to access this great member benefit!

Stress echocardiography (SE) has most frequently been applied to the assessment of known or suspected ischaemic heart disease. Stress-induced ischaemia results in the development of new or worsening regional wall motion abnormalities in the region subtended by a stenosed coronary artery; imaging increases the accuracy of the stress electrocardiogram for the recognition of ischaemia and high-risk features.


However, ischaemic heart disease is only one of the many diseases and conditions that can be assessed with SE. In recent years, SE has become an established method for the assessment of a wide spectrum of challenging clinical conditions, including systolic or diastolic heart failure, non-ischaemic cardiomyopathy, valvular heart disease, pulmonary hypertension (PH), athletes’ hearts, congenital heart disease (CHD), and heart transplantation. Due to the growing body of evidence supporting the use of SE beyond the evaluation of ischaemia, its increasing implementation in many echocardiography laboratories and its recognized diagnostic and prognostic value, it has thus become essential to establish guidance for its applications and performance. This paper provides recommendations for the clinical applications of SE to non-ischaemic heart disease. When clinically indicated, ischaemia can also be assessed in conjunction with assessments of non-ischaemic conditions, but it is not the focus of this document.




Stress Echocardiography Methods


SE provides a dynamic evaluation of myocardial structure and function under conditions of physiological (exercise) or pharmacological (inotrope, vasodilator) stress. The images obtained during SE permit matching symptoms with cardiac involvement. SE can unmask structural/functional abnormalities, which—although occult in the resting or static state—may occur under conditions of activity or stress, and lead to wall motion abnormalities, valvular dysfunction, or other haemodynamic abnormalities.


Exercise is the test of choice for most applications. As a general rule, any patient capable of physical exercise should be tested with an exercise modality, as this preserves the integrity of the electromechanical response and provides valuable information regarding functional status. Performing echocardiography at the time of exercise also allows links to be drawn among symptoms, cardiovascular workload, wall motion abnormalities, and haemodynamic responses, such as pulmonary pressure and transvalvular flows and gradients. Exercise echocardiography can be performed using either a treadmill or bicycle ergometer protocol. Semi-supine bicycle exercise is, however, technically easier than upright bicycle or treadmill exercise, especially when multiple stress parameters are assessed at the peak level of exercise.


Pharmacological stress does not replicate the complex haemodynamic and neurohormonal changes triggered by exercise. This includes psychological motivation and the response to exercise of the central and peripheral nervous systems, lungs and pulmonary circulation, right ventricle (RV) and left ventricle (LV), myocardium, valves, coronary circulation, peripheral circulation, and skeletal muscle. Dobutamine is the preferred alternative modality for the evaluation of contractile and flow reserve. Vasodilator SE is especially convenient for combined assessment of wall motion and coronary flow reserve, which may be indicated in dilated non-ischaemic cardiomyopathy and hypertrophic cardiomyopathy (HCM).


A flexible use of exercise, dobutamine, and vasodilator stresses maximizes versatility, avoids specific contraindications of each, and makes it possible to tailor the appropriate test to the individual patient ( Table 1 ).



Table 1

Targeted parameters to be assessed during SE


































































































































































































































































































SE indication SE query Type of stress Sequence of image acquisition Levels of image acquisition SE result SE report
Diastolic stress echo
Diastolic function Diastolic dysfunction ± SPAP increase as reason for HF symptoms and signs Exercise PW Doppler E and A, PW Tissue Doppler e , TR CW Doppler for SPAP Baseline, low workload, peak exercise E / e ′ increase ± SPAP increase Diastolic dysfunction
Cardiomyopathies
Hypertrophic cardiomyopathy LVOTO/diastolic dysfunction/dynamic MR/inducible ischaemia as reason for symptoms, or to plan treatment/lifestyle advice Exercise CW Doppler LVOT velocity, TR CW Doppler for SPAP, PW Doppler E and A, PW Tissue Doppler e ′, colour flow Doppler for MR, LV views for RWMA Baseline, low workload, peak exercise, for treadmill, immediately post-exercise LVOTO ± SPAP increase
E / e ′ increase ± SPAP increase
MR appearance/increase
RWMA
Exertion-induced LVOTO
Diastolic dysfunction
Dynamic MR
Inducible ischaemia
Dilated cardiomyopathy Contractile reserve, inducible ischaemia, diastolic reserve, SPAP change, dynamic MR, pulmonary congestion Exercise LV views, PW Doppler E and A, PW tissue Doppler e ′, TR CW Doppler for SPAP, Colour flow Doppler for MR, lung images Baseline, low workload, peak exercise Contractility increase
No contractility increase
E / e ′ increase ± SPAP increase
RWMA
Lung comets
MR increase/decrease
Contractile reserve
No contractile reserve
Pulmonary congestion
Dynamic MR/functional MR
Inotropic reserve
No inotropic reserve
CRT responder
Inotropic reserve, inducible ischaemia Dobutamine LV views Baseline, low dose ± high dose Contractility increase
No contractility increase
RWMA
Contractile reserve
No contractile reserve
Inducible ischaemia
Cardiac resynchronization therapy Inotropic reserve, viability in paced area Dobutamine LV views Baseline, low dose Contractility increase
No contractility increase
EF increase, paced area viability
Inotropic reserve
No inotropic reserve
CRT responder
Native valve disease
Aortic stenosis Severe AS with no symptoms Exercise LV views, colour flow Doppler for MR, TR CW Doppler for SPAP, AV CW Doppler, LVOT PW Doppler Baseline, low workload, peak exercise Symptoms ± LVEF drop/no increase a/o GLS ± RWMA ± SPAP increase ± MR appearance/increase ± gradient increase Severe AS with symptoms/pulmonary hypertension/dynamic MR/no contractile reserve/inducible ischaemia/non-compliant valve
Non-severe AS with symptoms Exercise AV CW Doppler, LVOT PW Doppler, LV views, Colour flow Doppler for MR Baseline, low workload, peak exercise Gradient increase + no/min AVA increase ± LVEF drop/no increase a/o GLS ± RWMA ± MR appearance/increase ± SPAP increase Non-compliant valve/no contractile reserve/inducible ischaemia/dynamic MR/pulmonary hypertension
Dobutamine AV CW Doppler, LVOT PW Doppler, LV views Baseline, low dose
Low–flow, low-gradient AS Dobutamine LVOT PW Doppler, AV CW Doppler, LV views Baseline, low dose No/min SV increase ± LVEF drop/no increase a/o GLS ± gradient increase ± no/min AVA increase No flow reserve/no LV contractile reserve/true-severe AS
Exercise LVOT PW Doppler, AV CW Doppler, LV views Baseline, low workload
Primary mitral regurgitation Severe MR with no symptoms Exercise LV views, TR CW Doppler for SPAP Baseline, low workload, peak exercise Symptoms, SPAP increase, LV EF failure to increase Severe MR with symptoms/pulmonary hypertension/no contractile reserve
Non-severe MR with symptoms Exercise Colour flow Doppler for MR, LV views, TR CW Doppler for SPAP Baseline, low workload, peak exercise MR increase
No MR increase
Severe MR with symptoms
Symptoms unrelated with MR
Secondary mitral regurgitation Change in MR severity with exertion ± SPAP increase Exercise Colour flow Doppler for MR, TR CW Doppler for SPAP, LV views Baseline, low workload, peak exercise MR increase ± SPAP increase
MR decrease
Dynamic MR, assess severity
Functional MR
Severe AR with no symptoms Exercise LV views Baseline, low workload, peak exercise Symptoms
EF failure to increase
Severe AR with symptoms/no LV contractile reserve
Aortic Regurgitation Non-severe AR with symptoms Exercise LV views, Colour flow Doppler for MR, TR CW Doppler for SPAP Baseline, low workload, peak exercise RWMA ± SPAP increase ± MR appearance/increase Inducible ischaemia/pulmonary hypertension/dynamic MR
Severe MS with no symptoms Exercise TR CW Doppler for SPAP Baseline, low workload, peak exercise Symptoms ± SPAP increase Severe MS with symptoms/pulmonary hypertension
Mitral stenosis Non-severe MS with symptoms Exercise TR CW Doppler for SPAP, MV CW Doppler for mean gradient Baseline, low workload, peak exercise MV gradient increase ± SPAP increase Severe MS
Dobutamine MV CW Doppler for mean gradient Baseline, low dose
Multivalvular disease Discordance in between symptoms and severity of valve disease Exercise Combination on the above depending on combination of features at baseline Baseline, low workload, peak exercise Re-evaluate symptoms/severity of valve disease Symptoms due or not to valve disease
Post valve procedures
Aortic valve prosthesis Stenosis/PPM with or without low flow Exercise AV CW Doppler, LVOT PW Doppler, TR CW Doppler for SPAP, LV views, Colour flow Doppler for MR Baseline, low workload, peak exercise Symptoms ± gradient increase + no/min EOA increase ± SPAP increase ± RWMA ± MR appearance/increase Significant stenosis or PPM/inducible ischaemia/dynamic MR
Dobutamine AV CW Doppler, LVOT Doppler, LV views Baseline, low dose
Mitral valve prosthesis Stenosis/PPM Exercise TR CW Doppler for SPAP, MV CW Doppler for mean gradient Baseline, low workload, peak exercise Symptoms ± gradient increase ± SPAP increase Significant stenosis or PPM
Dobutamine MV CW Doppler for mean gradient Baseline, low workload
Mitral valve annuloplasty Iatrogenic MS Exercise TR CW Doppler for SPAP, MV CW Doppler for mean gradient Baseline, low workload, peak exercise Gradient increase ± SPAP increase Iatrogenic MS
Dobutamine MV CW Doppler for mean gradient Baseline, low workload
Pulmonary hypertension
Pulmonary hypertension Symptoms and SPAP on exertion Exercise TR CW Doppler for SPAP, RV views Baseline, low workload, peak exercise SPAP increase Regrade severity
Cor pulmonale RV contractile reserve and SPAP Exercise RV views, TR CW Doppler for SPAP Baseline, low workload, peak exercise RV contractility increase RV contractile reserve
Athlete’s heart
Symptomatic athlete Assess response to exercise and symptoms Exercise LV views, LVOT CW Doppler for LVOTO, TR CW Doppler for SPAP, Colour flow Doppler for MR, lung images Baseline, low workload, peak exercise RWMA
LVOTO
Pathologic SPAP increase
MR appearance/increase
Lung comets
Induced ischaemia
LVOTO
Pulmonary hypertension
Dynamic MR
Pulmonary congestion
Congenital heart disease
Atrial septal defect SPAP and RV contractile reserve Exercise TR CW Doppler, RV views Baseline, low workload, peak exercise SPAP increase
RV contractility increase
Regrade severity
RV contractile reserve
RV contractile reserve Dobutamine RV views Baseline, low workload RV contractility increase RV contractile reserve
Tetralogy of Fallot RV and LV contractile reserve Exercise RV views, TAPSE, PW Tissue Doppler Baseline, low workload, peak exercise RV/LV contractility increase RV/LV contractile reserve
Aortic coarctation Assessment of severity and of LV contractile reserve Exercise Descending aorta CW Doppler, LV views Baseline, low workload, peak exercise Gradient increase
LV contractility increase
Regrade severity
LV contractile reserve
Univentricular hearts Assessment of contractile reserve and haemodynamic consequences of exercise Exercise Ventricular views, colour flow Doppler to detect atrio-ventricular valve regurgitation, CW Doppler to measure gradients Baseline, low workload, peak exercise Contractility increase
Other abnormalities
Contractile reserve
Describe and grade

AR , aortic regurgitation; AV , aortic valve; CW , continuous wave; EF , ejection fraction; LV , left ventricle; LVOTO , LV outflow tract obstruction; MR , mitral regurgitation; MS , mitral stenosis; MV , mitral valve; PW , pulse wave; RV , right ventricle; RWMA , regional wall motion abnormality; PPM , prosthesis–patient mismatch; SPAP , systolic pulmonary artery pressure; TAPSE , tricuspid annular systolic plane excursion; TR , tricuspid regurgitation.

Cor pulmonale refers to the altered structure (e.g. hypertrophy or dilatation) and/or impaired function of the RV that results from pulmonary hypertension.


e ′ often refers to averaged septal and lateral velocities, though either septal or lateral velocity can be used since the goal is to determine the change from rest to exercise.





Stress Echocardiography Methods


SE provides a dynamic evaluation of myocardial structure and function under conditions of physiological (exercise) or pharmacological (inotrope, vasodilator) stress. The images obtained during SE permit matching symptoms with cardiac involvement. SE can unmask structural/functional abnormalities, which—although occult in the resting or static state—may occur under conditions of activity or stress, and lead to wall motion abnormalities, valvular dysfunction, or other haemodynamic abnormalities.


Exercise is the test of choice for most applications. As a general rule, any patient capable of physical exercise should be tested with an exercise modality, as this preserves the integrity of the electromechanical response and provides valuable information regarding functional status. Performing echocardiography at the time of exercise also allows links to be drawn among symptoms, cardiovascular workload, wall motion abnormalities, and haemodynamic responses, such as pulmonary pressure and transvalvular flows and gradients. Exercise echocardiography can be performed using either a treadmill or bicycle ergometer protocol. Semi-supine bicycle exercise is, however, technically easier than upright bicycle or treadmill exercise, especially when multiple stress parameters are assessed at the peak level of exercise.


Pharmacological stress does not replicate the complex haemodynamic and neurohormonal changes triggered by exercise. This includes psychological motivation and the response to exercise of the central and peripheral nervous systems, lungs and pulmonary circulation, right ventricle (RV) and left ventricle (LV), myocardium, valves, coronary circulation, peripheral circulation, and skeletal muscle. Dobutamine is the preferred alternative modality for the evaluation of contractile and flow reserve. Vasodilator SE is especially convenient for combined assessment of wall motion and coronary flow reserve, which may be indicated in dilated non-ischaemic cardiomyopathy and hypertrophic cardiomyopathy (HCM).


A flexible use of exercise, dobutamine, and vasodilator stresses maximizes versatility, avoids specific contraindications of each, and makes it possible to tailor the appropriate test to the individual patient ( Table 1 ).



Table 1

Targeted parameters to be assessed during SE


































































































































































































































































































SE indication SE query Type of stress Sequence of image acquisition Levels of image acquisition SE result SE report
Diastolic stress echo
Diastolic function Diastolic dysfunction ± SPAP increase as reason for HF symptoms and signs Exercise PW Doppler E and A, PW Tissue Doppler e , TR CW Doppler for SPAP Baseline, low workload, peak exercise E / e ′ increase ± SPAP increase Diastolic dysfunction
Cardiomyopathies
Hypertrophic cardiomyopathy LVOTO/diastolic dysfunction/dynamic MR/inducible ischaemia as reason for symptoms, or to plan treatment/lifestyle advice Exercise CW Doppler LVOT velocity, TR CW Doppler for SPAP, PW Doppler E and A, PW Tissue Doppler e ′, colour flow Doppler for MR, LV views for RWMA Baseline, low workload, peak exercise, for treadmill, immediately post-exercise LVOTO ± SPAP increase
E / e ′ increase ± SPAP increase
MR appearance/increase
RWMA
Exertion-induced LVOTO
Diastolic dysfunction
Dynamic MR
Inducible ischaemia
Dilated cardiomyopathy Contractile reserve, inducible ischaemia, diastolic reserve, SPAP change, dynamic MR, pulmonary congestion Exercise LV views, PW Doppler E and A, PW tissue Doppler e ′, TR CW Doppler for SPAP, Colour flow Doppler for MR, lung images Baseline, low workload, peak exercise Contractility increase
No contractility increase
E / e ′ increase ± SPAP increase
RWMA
Lung comets
MR increase/decrease
Contractile reserve
No contractile reserve
Pulmonary congestion
Dynamic MR/functional MR
Inotropic reserve
No inotropic reserve
CRT responder
Inotropic reserve, inducible ischaemia Dobutamine LV views Baseline, low dose ± high dose Contractility increase
No contractility increase
RWMA
Contractile reserve
No contractile reserve
Inducible ischaemia
Cardiac resynchronization therapy Inotropic reserve, viability in paced area Dobutamine LV views Baseline, low dose Contractility increase
No contractility increase
EF increase, paced area viability
Inotropic reserve
No inotropic reserve
CRT responder
Native valve disease
Aortic stenosis Severe AS with no symptoms Exercise LV views, colour flow Doppler for MR, TR CW Doppler for SPAP, AV CW Doppler, LVOT PW Doppler Baseline, low workload, peak exercise Symptoms ± LVEF drop/no increase a/o GLS ± RWMA ± SPAP increase ± MR appearance/increase ± gradient increase Severe AS with symptoms/pulmonary hypertension/dynamic MR/no contractile reserve/inducible ischaemia/non-compliant valve
Non-severe AS with symptoms Exercise AV CW Doppler, LVOT PW Doppler, LV views, Colour flow Doppler for MR Baseline, low workload, peak exercise Gradient increase + no/min AVA increase ± LVEF drop/no increase a/o GLS ± RWMA ± MR appearance/increase ± SPAP increase Non-compliant valve/no contractile reserve/inducible ischaemia/dynamic MR/pulmonary hypertension
Dobutamine AV CW Doppler, LVOT PW Doppler, LV views Baseline, low dose
Low–flow, low-gradient AS Dobutamine LVOT PW Doppler, AV CW Doppler, LV views Baseline, low dose No/min SV increase ± LVEF drop/no increase a/o GLS ± gradient increase ± no/min AVA increase No flow reserve/no LV contractile reserve/true-severe AS
Exercise LVOT PW Doppler, AV CW Doppler, LV views Baseline, low workload
Primary mitral regurgitation Severe MR with no symptoms Exercise LV views, TR CW Doppler for SPAP Baseline, low workload, peak exercise Symptoms, SPAP increase, LV EF failure to increase Severe MR with symptoms/pulmonary hypertension/no contractile reserve
Non-severe MR with symptoms Exercise Colour flow Doppler for MR, LV views, TR CW Doppler for SPAP Baseline, low workload, peak exercise MR increase
No MR increase
Severe MR with symptoms
Symptoms unrelated with MR
Secondary mitral regurgitation Change in MR severity with exertion ± SPAP increase Exercise Colour flow Doppler for MR, TR CW Doppler for SPAP, LV views Baseline, low workload, peak exercise MR increase ± SPAP increase
MR decrease
Dynamic MR, assess severity
Functional MR
Severe AR with no symptoms Exercise LV views Baseline, low workload, peak exercise Symptoms
EF failure to increase
Severe AR with symptoms/no LV contractile reserve
Aortic Regurgitation Non-severe AR with symptoms Exercise LV views, Colour flow Doppler for MR, TR CW Doppler for SPAP Baseline, low workload, peak exercise RWMA ± SPAP increase ± MR appearance/increase Inducible ischaemia/pulmonary hypertension/dynamic MR
Severe MS with no symptoms Exercise TR CW Doppler for SPAP Baseline, low workload, peak exercise Symptoms ± SPAP increase Severe MS with symptoms/pulmonary hypertension
Mitral stenosis Non-severe MS with symptoms Exercise TR CW Doppler for SPAP, MV CW Doppler for mean gradient Baseline, low workload, peak exercise MV gradient increase ± SPAP increase Severe MS
Dobutamine MV CW Doppler for mean gradient Baseline, low dose
Multivalvular disease Discordance in between symptoms and severity of valve disease Exercise Combination on the above depending on combination of features at baseline Baseline, low workload, peak exercise Re-evaluate symptoms/severity of valve disease Symptoms due or not to valve disease
Post valve procedures
Aortic valve prosthesis Stenosis/PPM with or without low flow Exercise AV CW Doppler, LVOT PW Doppler, TR CW Doppler for SPAP, LV views, Colour flow Doppler for MR Baseline, low workload, peak exercise Symptoms ± gradient increase + no/min EOA increase ± SPAP increase ± RWMA ± MR appearance/increase Significant stenosis or PPM/inducible ischaemia/dynamic MR
Dobutamine AV CW Doppler, LVOT Doppler, LV views Baseline, low dose
Mitral valve prosthesis Stenosis/PPM Exercise TR CW Doppler for SPAP, MV CW Doppler for mean gradient Baseline, low workload, peak exercise Symptoms ± gradient increase ± SPAP increase Significant stenosis or PPM
Dobutamine MV CW Doppler for mean gradient Baseline, low workload
Mitral valve annuloplasty Iatrogenic MS Exercise TR CW Doppler for SPAP, MV CW Doppler for mean gradient Baseline, low workload, peak exercise Gradient increase ± SPAP increase Iatrogenic MS
Dobutamine MV CW Doppler for mean gradient Baseline, low workload
Pulmonary hypertension
Pulmonary hypertension Symptoms and SPAP on exertion Exercise TR CW Doppler for SPAP, RV views Baseline, low workload, peak exercise SPAP increase Regrade severity
Cor pulmonale RV contractile reserve and SPAP Exercise RV views, TR CW Doppler for SPAP Baseline, low workload, peak exercise RV contractility increase RV contractile reserve
Athlete’s heart
Symptomatic athlete Assess response to exercise and symptoms Exercise LV views, LVOT CW Doppler for LVOTO, TR CW Doppler for SPAP, Colour flow Doppler for MR, lung images Baseline, low workload, peak exercise RWMA
LVOTO
Pathologic SPAP increase
MR appearance/increase
Lung comets
Induced ischaemia
LVOTO
Pulmonary hypertension
Dynamic MR
Pulmonary congestion
Congenital heart disease
Atrial septal defect SPAP and RV contractile reserve Exercise TR CW Doppler, RV views Baseline, low workload, peak exercise SPAP increase
RV contractility increase
Regrade severity
RV contractile reserve
RV contractile reserve Dobutamine RV views Baseline, low workload RV contractility increase RV contractile reserve
Tetralogy of Fallot RV and LV contractile reserve Exercise RV views, TAPSE, PW Tissue Doppler Baseline, low workload, peak exercise RV/LV contractility increase RV/LV contractile reserve
Aortic coarctation Assessment of severity and of LV contractile reserve Exercise Descending aorta CW Doppler, LV views Baseline, low workload, peak exercise Gradient increase
LV contractility increase
Regrade severity
LV contractile reserve
Univentricular hearts Assessment of contractile reserve and haemodynamic consequences of exercise Exercise Ventricular views, colour flow Doppler to detect atrio-ventricular valve regurgitation, CW Doppler to measure gradients Baseline, low workload, peak exercise Contractility increase
Other abnormalities
Contractile reserve
Describe and grade

AR , aortic regurgitation; AV , aortic valve; CW , continuous wave; EF , ejection fraction; LV , left ventricle; LVOTO , LV outflow tract obstruction; MR , mitral regurgitation; MS , mitral stenosis; MV , mitral valve; PW , pulse wave; RV , right ventricle; RWMA , regional wall motion abnormality; PPM , prosthesis–patient mismatch; SPAP , systolic pulmonary artery pressure; TAPSE , tricuspid annular systolic plane excursion; TR , tricuspid regurgitation.

Cor pulmonale refers to the altered structure (e.g. hypertrophy or dilatation) and/or impaired function of the RV that results from pulmonary hypertension.


e ′ often refers to averaged septal and lateral velocities, though either septal or lateral velocity can be used since the goal is to determine the change from rest to exercise.





Haemodynamic Effects of Myocardial Stressors


All SE stressors have associated haemodynamic effects. As a common outcome, they result in a myocardial supply/demand mismatch and may induce ischaemia in the presence of a reduction in coronary flow reserve, due to epicardial stenoses, LV hypertrophy, or microvascular disease. Exercise and inotropic stressors normally provoke a generalized increase of regional wall motion and thickening, with an increment of ejection fraction (EF) mainly caused by a reduction of systolic dimensions.


Exercise


During treadmill or bicycle exercise, heart rate normally increases two- to three-fold, contractility three- to four-fold, and systolic blood pressure by ≥50%, while systemic vascular resistance decreases. LV end-diastolic volume initially increases (increase in venous return) to sustain the increase in stroke volume through the Frank–Starling mechanism and later falls at high heart rates. For most patients, both duration of exercise and maximum workload and achieved heart rate are slightly lower in the supine bicycle position, due primarily to the development of leg fatigue at an earlier stage of exercise. Then, for a given level of stress in the supine position, the end-diastolic volume and mean arterial blood pressure are higher. These differences contribute to a higher wall stress and an associated increase in myocardial oxygen demand and filling pressures compared with an upright bicycle test. In response to exercise, there is a variable increase in pulmonary artery pressure (PAP), for which the degree depends on the intensity of test. Coronary blood flow also increases three- to five-fold in normal subjects, but much less (<2-fold) in one-third of patients with non-ischaemic dilated or HCM. In the presence of a reduction in coronary flow reserve, the regional myocardial oxygen-supply mismatch determines subendocardial myocardial ischaemia and regional dysfunction, which can be observed in 10–20% of patients with angiographically normal coronary arteries and either dilated or HCM.


Dobutamine


Dobutamine acts directly and mainly on β-1 adrenergic receptors of the myocardium, producing an increase in heart rate and contractility. The increase in the determinants of myocardial oxygen consumption is substantial: heart rate increases two- to three-fold, end-diastolic volume 1.2-fold, and systolic arterial pressure 1.5- to 2-fold. Myocardial contractility (measured as elastance) increases over four-fold in normal subjects and much less so (less than two-fold) in patients with dilated cardiomyopathy. The activation of β-2 adrenergic receptors by dobutamine contributes to the mild decrease in blood pressure common at higher dobutamine dose, through a vasodilatatory effect. During dobutamine infusion, LV end-systolic volume decreases to a greater extent than LV end-diastolic volume while the cardiac output increases as a result of increased heart rate and stroke volume. Compared with exercise, there is a lesser recruitment of venous blood volume with dobutamine, so that LV volumes and wall stress increase less with dobutamine.


Vasodilators


Vasodilator SE can be performed with dipyridamole, adenosine, or regadenoson, all using the same metabolic pathway, increasing endogenous adenosine levels (dipyridamole), increasing exogenous adenosine levels (adenosine), or directly acting on vascular A 2A adenosine receptors (with higher receptor specificity for regadenoson and less potential for complications). These vasodilatators produce a small decrease in blood pressure, a modest tachycardia, and a minor increase in myocardial function. In the presence of a critical epicardial stenosis or microcirculatory dysfunction, vasodilator administration results in heterogeneity of coronary blood flow between areas subtended by stenosed vs. normal coronary arteries, a supply–demand mismatch, and a decrease in subendocardial flow in areas of coronary artery stenosis via steal phenomena.




Stress Echocardiography Protocols


Treadmill


The advantage of treadmill exercise echocardiography is the widespread availability of the treadmill system and the wealth of clinical experience that has accumulated with this form of stress testing (Supplementary data online 1). Commonly used treadmill protocols are the Bruce and modified Bruce protocols. The latter has with two warmup stages, each lasting 3 min. The first is at 1.7 mph and a 0% grade, and the second is at 1.7 mph and a 5% grade.


Bicycle


Bicycle ergometer exercise echocardiography may be performed with the patient upright or on a special semi-recumbent bicycle, which may have left lateral tilt to facilitate apical imaging. The patient pedals against an increasing workload at a constant cadence ( Figure 1 ). The workload is escalated in a stepwise fashion while imaging is performed. Successful bicycle stress testing requires the patient’s cooperation to maintain the correct cadence and coordination to perform the pedalling action. Causes of test cessation and definition of abnormal stress test are listed in Figure 2 .




Figure 1


Exercise echocardiography protocol and parameters that can be assessed at each stage. bpm, beats per minute; LV , left ventricle; LVOT , LV outflow tract; MR , mitral regurgitation; E / e ′, ratio of early transmitral diastolic velocity to early TDI velocity of the mitral annulus; RWM , regional wall motion; RV , right ventricle; SPAP , systolic pulmonary artery pressure; W , watts; rpm , rotations per minute. Valve refers to aortic or mitral valve.



Figure 2


Diagnostic end-points, causes of test cessation and definition of abnormal stress test. Asterisk indicates specific targeted features relates to cut-off values associated with poor outcome in defined population (i.e. >50 mmHg intraventricular obstruction). NS , non-sustained; SVT , sustained ventricular tachycardia.


Dobutamine


For detection of inotropic response in HF patients, stages of 5 min are used, starting from 5 up to 20 μg/kg/min ( Figure 3 ). To fully recruit the inotropic reserve in patients with HF and under β-blocker therapy, doses up to 40 μg/kg/min may be required. Atropine coadministration is associated with higher rate of complications in those with a history of neuropsychiatric symptoms, reduced LV function, or small body habitus. In assessment of the patient with possible severe aortic valve stenosis, the maximal dose is usually 20 μg/kg/min; higher doses are less safe and probably unnecessary. The dobutamine infusion is started as usual at 5 μg/kg/min but titrated upward in steps of 2.5–5 μg/kg/min every 5–8 min. After each increment in dobutamine dose, a period of 2–3 min before starting the image acquisition will allow the haemodynamic response to develop.




Figure 3


Dobutamine echocardiography protocol. A low-dose test is recommended in patients with low-flow, low-gradient aortic stenosis and reduced LVEF. In patients with heart failure that are receiving beta-blocker therapy, high doses up to 40 μg/kg/min (without atropine) of dobutamine are often required. AVA , aortic valve area; LV , left ventricle; LVOT , LV outflow tract; RWM , regional wall motion; SV , stroke volume. Valve refers to aortic or mitral valve.


Vasodilators


Administration of dipyridamole (0.84 mg/kg over 6 min or the same dose over 10 min, or an initial dose of 0.56 mg/kg over 4 min sometimes followed by 4 min of no dose and additional 0.28 mg/kg over 2 min), adenosine (140 μg/kg/min over 4–6 min to a maximum of 60 mg), or regadenoson (0.4 mg over 10 s) is performed without the administration of atropine.


Image Acquisition


The echocardiographic imaging acquisition protocol of choice varies according to the objectives of the test and the stressor used ( Tables 1 and 2 ). Several parameters can be assessed, including ventricular and valvular function, valvular and subvalvular gradients, regurgitant flows, left and right heart haemodynamics including systolic pulmonary artery pressure (SPAP), ventricular volumes, B-lines (also called ultrasound lung comets, a sign of extravascular lung water), and epicardial coronary flow reserve.



Table 2

SE cut-off values associated with clinical significance, outcome or limited response to therapy








































Parameters Cut-off values
Intraventricular obstruction


  • LVOT gradient >50 mmHg

Inadequate contractile reserve


  • ΔWMSI <0.25 in dilated cardiomyopathy (ESE, DSE)



  • ΔLVEF <7.5% in patients with biventricular pacing and heart failure (ESE, DSE)



  • ΔLVEF<4–5% in Primary MR, AR (ESE)



  • Δ global longitudinal strain <2% in Primary MR (ESE)

Inadequate flow reserve


  • Δ stroke volume <20% (DSE)

Dynamic mitral regurgitation


  • ΔEROA  ≥10–13 mm 2 in MR patients (ESE)

Systolic pulmonary hypertension


  • SPAP ≥ 60 mmHg (ESE)

Limited valve compliance/fixed stenosis


  • Mean transmitral gradient in MS




    • >15 mmHg (ESE)



    • >18 mmHg (DSE)




  • Mean transaortic gradient in AS




    • ΔMPG  >18–20 mmHg (ESE)


Prosthesis dysfunction or PPM


  • Mean transmitral gradient in MV Prosthesis




    • >10 mmHg (ESE or DSE)




  • Mean transaortic gradient in AV Prosthesis




    • >20 mmHg (ESE or DSE)


Functional MS after mitral valve repair


  • Δ mean transmitral gradient >7 mmHg

RV dysfunction


  • TAPSE <19 mm in Primary MR (ESE)

Increase in B-lines


  • >5 (28-region chest scan) (ESE)

Reduced coronary flow reserve (CFR)


  • CFR <2.0 (VSE)


Δ , changes from rest to peak stress; AS , aortic stenosis; CFR , coronary flow reserve; DSE , dobutamine stress echocardiography; EROA , effective regurgitant orifice area; ESE , exercise stress echocardiography; LVOT , left ventricular outflow tract; MS , mitral stenosis; MR , mitral regurgitation; RV , right ventricle; SPAP , systolic pulmonary artery pressure; TAPSE , tricuspid annulus plane systolic excursion; VSE , vasodilatator stress echocardiography.


When either treadmill or upright bicycle exercise is performed, most protocols rely on post-exercise imaging, which is generally limited to apical, parasternal and/or subcostal views. It is imperative to complete post-exercise imaging as soon as possible since wall motion changes, valve gradients, and pulmonary haemodynamics normalize quickly during recovery. To accomplish this, the patient is moved immediately from the treadmill to an imaging table and placed in the left lateral decubitus position so that imaging can be completed within 1–2 min. However, when the LVOT gradient is assessed in athletes or HCM patients, it may be more relevant to obtain this measurement with the patient in the upright position, since cardiac symptoms in these patients are noted most commonly in this position, during or immediately after exercise.


The most important advantage of semi-supine bicycle exercise is the chance to obtain images during the various levels of exercise, rather than relying on post-exercise imaging. With the patient in the supine position, it is relatively easy to record images from multiple views during graded exercise. With upright bicycle ergometer testing, by having the patient lean forward over the handlebars or extend the arms, apical images can be obtained in the majority. During supine exercise echocardiography, imaging should thus be performed throughout the test, at peak exercise, and very early in the recovery phase.


Interpretation of the Test


The type of SE protocol used should always be included in the report. During both exercise and inotropic stress, a normal response involves the augmentation of function in all segments and increases in LVEF and cardiac output. The presence of a new or worsening wall motion abnormality identifies ischaemia while the improvement of regional wall motion by ≥1 grade in dysfunctioning segments characterizes recruitable viable myocardium. Global contractile reserve in patients with no regional resting dysfunction is often defined as an increase by ≥5% in LVEF while a flow reserve is defined as an increase in forward stroke volume by ≥20%. Any change in cardiac function (improvement or worsening in wall motion, EF, or global longitudinal function as assessed by strain rate imaging), haemodynamic parameters (stroke volume, SPAP, E / e ′, LV outflow tract (LVOT) gradients), severity of valvular disease (improvement or worsening of mitral regurgitation (MR), aortic valve area and pressure gradients) must be reported according to the specific diagnostic question. Blood pressure and heart rate must also be reported to understand the relationship between contractile and haemodynamic responses. During vasodilator SE, the presence of viability and/or ischaemia and the degree of coronary flow reserve are described.


Safety


SE is an extremely safe diagnostic tool in the evaluation of patients with suspected or known CAD. In patients with non-ischaemic heart disease, only limited or indirect data are available regarding the safety of the tests. Further studies and registries are needed to establish the safety of various stressors in these populations.




In the SE laboratory, a variety of parameters may be assessed: ventricular function, valvular gradients and regurgitant flows, left and right heart haemodynamics including pulmonary artery systolic pressure, and ventricular volumes. As it is not feasible to assess all possible parameters during stress, the variables of potential diagnostic interest should be prioritized for the individual patient based on the perceived importance of each. Physiology determines the choice of the stress and the key echocardiographic variables of interest. Exercise is the test of choice for most applications. Bicycle ergometer stress testing is optimal for obtaining Doppler data during exercise, but patient endurance is generally less than with treadmill exercise unless the patient has trained cycling muscles. Dobutamine is the preferred alternative modality for the evaluation of contractile reserve (as in dilated cardiomyopathy or aortic valve stenosis with LV dysfunction). Vasodilation is the preferred modality for the evaluation of coronary flow reserve, which can provide prognostically relevant information in cardiomyopathy.


Key Points




Diastolic Stress Echocardiography


The importance of diastolic dysfunction for symptoms such as shortness of breath, exertional fatigue, or poor exercise capacity has been increasingly recognized, and diastolic dysfunction is considered to be the main cause in ∼40% of patients presenting with clinical HF.


Diastolic SE generally refers to the use of exercise Doppler echocardiography to detect impaired LV diastolic function reserve and the resulting increase in LV filling pressures in patients with unexplained dyspnoea or subclinical diastolic dysfunction (e.g. diabetic cardiomyopathy, hypertensive patients). Nonetheless, it is mainly of value in patients with suspected HF with preserved LVEF and borderline diastolic abnormalities at rest. Figure 4 summarizes when diastolic SE should be considered in clinical practice. Figures 5 and 6 show examples of diastolic stress results.




Figure 4


Diastolic SE performed for the assessment of dyspnoea, breathlessness, or exertional fatigue. Asterik indicates criteria used to diagnose heart failure with preserved LV EF. CO , cardiac output; Exer , exercise; LVOTO , LV outflow tract obstruction; MR , mitral regurgitation; RWMA , regional wall motion abnormality; SV , stroke volume; E , early transmitral diastolic velocity; e ′, early TDI velocity of the mitral annulus; SPAP , systolic pulmonary artery pressure; PH , pulmonary hypertension; TR , tricuspid regurgitation; HFeEF , heart failure with preserved LVEF.



Figure 5


Mitral flow and annular velocity at rest, during supine bicycle exercise and recovery in a 71-year-old man with exertional dyspnoea. At baseline, mitral inflow pattern revealed abnormal relaxation with normal range of E / e ′. However, mitral inflow pattern dramatically changed after 5 min of supine bicycle exercise from normal to restrictive physiology with significantly elevated E / e ′. The variable e ′ refers to septal velocities.



Figure 6


Mitral flow and annular velocity at rest, during supine bicycle exercise, and in recovery in a 56-year-old woman with hypertension and exertional dyspnoea. Because of tachycardia even with mild exercise, E / e ′ could not be measured at 50 W of exercise. Note that E / e ′ was significantly elevated even after cessation of exercise and was higher than at rest and during exercise.


Exercise using a supine bicycle is the recommended modality for diastolic SE as it allows the acquisition of Doppler recordings throughout the test and the non-invasive assessment of exercise diastolic function reserve. Treadmill exercise SE is an alternative as diastolic abnormalities may persist after exercise. Preload augmentation by passive leg raise might also represent a non-exercise alternative since it provides additional information identifying patients with exercise-induced LV filling pressure elevation and lower exercise capacity.


A diastolic SE protocol can be used as a stand-alone test or it can be added to the assessment of regional wall motion abnormalities. Mitral E, A, E/A (1–2 mm sample volume pulsed wave Doppler placed at the tip of mitral valve), e ′ (5- to 10-mm sample volume pulsed wave tissue Doppler, septal and/or lateral mitral annulus, Nyquist limit at 15–20 cm/s with adjustment of gain and filter), E / e ′, and SPAP should be recorded at baseline, at low-level exercise, and during the recovery period. The variables E and e ′ are usually recorded at 100–110 bpm, when E and A waves are not yet fused. Although less evidence is available, post-exercise assessment during the recovery period can be performed, especially when there has been an abrupt increase in heart rate with low level of exercise. Recordings are obtained using the apical four-chamber view and a total of 5–10 cardiac cycles should be recorded. For the patient unable to exercise, diastolic function can be assessed during passive leg raise. The patient’s legs are passively elevated for 3 min, and similar Doppler-echocardiographic parameters are recorded. The limitations of E / e ′ as non-invasive estimates of LV filling pressures as assessed by resting echocardiography are also applicable for diastolic SE.


Interpretation and Haemodynamic Correlation


In middle-aged healthy subjects, the E / e ′ ratio does not change significantly with exercise because of proportional increases in both the mitral inflow and annular velocities ; this represents the normal diastolic response for exercising subjects. Conversely, an increase in the E / e ′ ratio and/or SPAP with exercise has been shown to parallel increases in the LV end-diastolic pressure as recorded by invasive measurements.


A diastolic exercise SE is definitively normal if the septal E / e ′ is <10 at rest and with exercise, and the peak tricuspid regurgitation (TR) velocity is <2.8 m/s at rest and with stress. A study is abnormal when the average E / e ′ ratio is >14, and the septal e ′ velocity is <7 cm/s at baseline. Peak TR velocity is >3.1 m/s with exercise usually indicates an abnormal response, but aerobically trained athletes can normally generate higher pressures. Additionally, SPAP at rest and with exercise increases with advancing age. Thus, the workload achieved as well as the patient’s age must be taken into consideration. Systolic pulmonary artery pressure measurement with exercise has been found to be helpful in aiding the assessment of diastolic filling pressure with exercise. It has been shown that the upper normal SPAP is <35 mmHg at rest and <43 mmHg at exercise. Exercise E /septal e ′ >13, lower amplitude of changes in diastolic longitudinal velocities, and induced PH (SPAP ≥ 50 mmHg) are markers of adverse outcomes.


Passive leg raise can induce heterogeneous changes in mitral inflow and mitral annular velocities in patients with abnormal relaxation. Patients with relaxation abnormality and E / e ′ < 15 at rest but increased E / e ′ > 15 during leg raise, defined as ‘unstable’ relaxation abnormality, were older, more often female, and had lower diastolic reserve and exercise capacity when compared with patients with persistent E / e ′ < 15. In addition, e ′ response to passive leg raise was significantly correlated with diastolic reserve indexes during exercise.


Since e ′ velocity is inversely correlated with the time constant of isovolumic relaxation ( τ ) and administration of dobutamine enhanced LV relaxation and early diastolic recoil, an increase in e ′ velocity during dobutamine SE could be an indicator of myocardial longitudinal diastolic functional reserve. Of note, persistent restrictive LV filling pattern during dobutamine SE is associated with poorer long-term outcome in patients with ischaemic cardiomyopathy.


Impact on Treatment


The diagnosis of impaired diastolic reserve in conjunction with increased E / e ′, an estimate of LV filling pressure, in patients with suspected HF with preserved LVEF may be beneficial in guiding therapy or monitoring the effect of treatment.




Exercise-induced changes in E /e′ allow recognition of impaired LV diastolic function reserve and the resulting increase in LV filling pressures in patients with dyspnoea and suspected heart failure with preserved LVEF. Exercise Doppler echocardiography is helpful in the assessment of the symptomatic patient with normal or equivocal diastolic function during resting images.


Key Points




Hypertrophic Cardiomyopathy


Hypertrophic cardiomyopathy is a heterogeneous inherited cardiomyopathy with variable phenotypic expression. Although some patients are asymptomatic, others have HF, and some present with sudden death. Disease progression is often due to diastolic dysfunction, MR, and LVOT obstruction (LVOTO).


Exercise SE is safe and commonly used to assess inducible LVOTO, especially in patients with equivocal symptoms, to determine functional capacity prior to a corrective therapeutic procedure, and for individual risk stratification ( Figure 7 ). In the ESC guidelines, exercise echocardiography is recommended in symptomatic patients if bedside manoeuvres fail to induce LVOTO ≥ 50 mmHg and is rated as class IIa, level of evidence B in the ACC/AHA guidelines. Post-prandial gradients are higher than those performed in the fasting state and pre-treatment with β-blockers is known to reduce the incidence and severity of exercise-induced LVOTO.




Figure 7


Example of dynamic intraventricular obstruction during exercise echocardiography in a dyspneic patient with HCM. Top : Increase in left ventricular outflow tract velocity and gradient associated with a marked flow acceleration ( red arrow ) (note the laminar flow at rest ( yellow arrow )). Note the greater increase in intraventricular gradient after exercise due to the decrease in venous return. Bottom : Systolic anterior motion of the mitral valve identified on 2D ( left ) and M-mode ( right ) echocardiography ( white arrows ).


Approximately one-third of patients have resting systolic anterior motion of the mitral valve leaflets that results in LVOTO, while another third have latent obstruction unmasked only during manoeuvres that change loading conditions (standing, Valsalva, nitrates, exercise) and LV contractility. Of note, pharmacological provocation with dobutamine is not recommended, as it is not physiological, can be poorly tolerated, and can induce LVOTO even in normal subjects. However, dobutamine or isoproterenol is used routinely in the operating room both pre- and post bypass to evaluate septal contact of the mitral valve leaflets and to guide the extent of the myectomy and surgical management of the mitral valve, which may require plication. Often, amyl nitrite may not reproduce exercise-induced gradients.


Exercise Doppler echocardiography can be performed in a standing, sitting, or semi-supine position. The echocardiographic parameters are assessed during exercise and at the beginning of the recovery period, when preload decreases. In patients with equivocal symptoms, if exercise SE does not produce LVOTO gradients, assessment for post-exercise standing gradients should be considered. An upright position after exercise causes a greater decrease in preload. Assessment of post-prandial exercise standing gradient may also be considered. In patients already under β-blockers, treatment should not be withdrawn prior to exercise SE.


The following parameters can be evaluated during the test, especially during semi-supine exercise: blood pressure, symptoms, heart rate, electrocardiographic changes, LVOTO, LV systolic/diastolic ( E / e ′) function, MR, and SPAP ( Figures 8–10 ). Post-exercise testing mainly focuses on LVOTO induction, SPAP, and diastolic parameters. Effort should be made to distinguish the subvalvular gradient from the MR jet. A limited exercise capacity, an abnormal blood pressure response (hypotensive or blunted response), significant ST-depression, inducible wall motion abnormalities, blunted coronary flow reserve (dipyridamole test), exercise LVOTO (>50 mmHg), and blunted systolic function reserve are all parameters of worse prognosis. Dynamic increase in MR, often in relation to systolic anterior motion of the mitral valve, blunted changes in e ′ (no diastolic reserve), increase in E / e ′, and PH at exercise are all markers of poor exercise tolerance. 2D strain imaging of LV function can be accurately performed at 100–120 bpm and is more sensitive to identify subtle changes in intrinsic myocardial function. A blunted increase in global longitudinal strain (limited contractile reserve) favours diagnosis of HCM rather than athletes’ heart. Intriguingly, some patients can display a paradoxical decrease in LVOTO during exercise, which is associated with a more favourable outcome and suggests alternative reasons for dyspnoea.




Figure 8


Significant increase in mitral regurgitation during exercise echocardiography (mild at rest and severe at exercise) in a patient with HCM.



Figure 9


Dyspneic patient with HCM, increased dynamic intraventricular obstruction ( top ) and left ventricular filling pressure ( bottom , E / e ′) during exercise echocardiography.



Figure 10


Breathless patient with HCM and chronic obstructive pulmonary disease. Exercise echocardiography reveals the presence of systolic (increase in global longitudinal strain [GLS]) and diastolic (increase in e ′) reserve without significant increase in E / e ′ (left ventricular filling pressure). These data suggest that the symptoms are mainly due to the pulmonary disease.


Impact on Treatment


Identification of LVOTO (haemodynamically significant if ≥50 mmHg) is important in the management of symptoms and assessment of individual risk. Resting LVOTO carries a moderate increase in overall mortality and risk of sudden cardiac death in patients with HCM. Surgical myectomy with or without mitral valve surgery or alcohol septal ablation may be indicated in symptomatic patients with haemodynamically significant LVOTO despite optimal medical treatment. Exercise SE also allows monitoring of the efficacy of β-blocker therapy.




Exercise SE is an important and useful tool for evaluation of symptoms and monitoring the response to therapy in patients with HCM. Dynamic LVOTO (>50 mmHg) can be easily assessed. Abnormal blood pressure response to exercise, blunted contractile (systolic) and diastolic reserve, and worsened MR are associated with poor exercise capacity and outcome. SE is not indicated when a gradient >50 mmHg is present at rest or with Valsalva manoeuvre.


Key Points




Heart Failure with Depressed LV Systolic Function and Non-ischaemic Cardiomyopathy


Non-ischaemic cardiomyopathy is relatively common in patients presenting with HF and is associated with a high mortality rate. In these patients, increased circulating catecholamines are accompanied by a decreased density and downregulation of β-receptors, which is associated with poor response to β adrenergic blocking agents and worse outcomes. Studies have shown that myocardial contractile response to exogenous catecholamines has important prognostic implications.


In early stages of heart failure, when resting LVEF is still preserved, a blunted contractile reserve can identify incipient, pre-clinical myocardial damage. Such a response may be used in detection of early chemotherapy-induced cardiotoxicity, thalassemia, and hypertensive and diabetic cardiomyopathy. In the overt stage of non-ischaemic cardiomyopathy, residual myocardial contractile reserve as assessed by SE can assist to distinguish ischaemic from non-ischaemic disease, for outcome assessment, and aid to clinical decision making.


Although dobutamine SE is most often used, exercise SE can also be performed. Several protocols including low-dose (10 μg/kg/min) to high-dose (40 μg/kg/min) dobutamine SE have been used to evaluate contractile reserve, changes in LV volumes and EF. There is, however, no consensus on the optimal dobutamine protocol to evaluate patients with non-ischaemic cardiomyopathy. One of the advantages of high-dose compared with low-dose dobutamine in this cohort of patients is that the high dose is more likely to invoke a contractile response especially if the patients are on β-blockers, thus decreasing the chances of a false-negative finding. However, high-dose dobutamine is more likely to cause significant arrhythmias.


Alternatively, exercise SE protocols may be used, sometimes with longer stages to permit acquisition of more data at each stage, including systolic and diastolic reserve, SPAP, dynamic MR, or B-lines ( Figure 11 ). B-lines or lung comets are discrete, laser-like, vertical, hyperechoic images that arise from the pleural line, extend to the bottom of the screen without fading, and move synchronously with respiration.




Figure 11


Lung ultrasound (third right intercostal space) at rest ( left upper panel ) and immediately after exercise ( left lower panel ). On the right panels, the schematic drawing showing normal, parallel, horizontal A-lines at rest ( right upper panel ), and three vertical B-lines ( arrows ) departing from the pleural line after exercise ( right lower panel ). The exercise-induced appearance of B-lines (also called ultrasound lung comets, ULC) reflects the acute increase of extravascular lung water. ULC presence is frequently associated with elevated PCWP and/or reduced EF.


Dipyridamole SE is rarely used to assess contractile reserve, but may be useful in patients on β-blockers, and is associated with less arrhythmias.


In patients with either preserved or reduced LVEF, the absence of contractile reserve is often associated with limited coronary flow reserve. It is a marker of latent LV systolic dysfunction and subclinical cardiomyopathy.


In dilated non-ischaemic cardiomyopathy, patients with significant improvement in their wall motion score index and LVEF during dobutamine infusion have a better survival rate, fewer hospitalizations for HF, and an increase in the LVEF during follow-up. Alternatively, dobutamine SE can be used in patients with HF with ambulation difficulties. Patients with inotropic contractile reserve respond better to β-blockers. The presence of inotropic contractile reserve was also associated with a decrease in the need for cardiac transplantation and correlates inversely with the extent of interstitial fibrosis and scarred myocardium. These findings have also been extended in specific aetiology of cardiomyopathy, including in peripartum and in HIV cardiomyopathy, where the presence of inotropic contractile reserve correlates with subsequent recovery of LV function at follow-up and also better outcomes. When the purpose of the dobutamine SE is to seek for LV contractile reserve and not myocardial ischaemia, atropine is not adiministered. In patients with non-ischaemic cardiomyopathy, blunted coronary flow reserve or the absence of contractile reserve during dipyridamole test is also a marker of poor prognosis.


In both patients with preserved or reduced LVEF, the presence and the amount of B-lines (lung comets) likely correlate with the estimated LV filling pressure and the presence of pulmonary interstitial edema. The demonstration of B-lines during exercise SE seems a feasible way for demonstrating that exertional dyspnoea is related to pulmonary congestion.


Differentiating Non-ischaemic from Ischaemic Cardiomyopathy


Differentiating non-ischaemic from ischaemic cardiomyopathy may be challenging since patients with non-ischaemic cardiomyopathy may have frequent episodes of chest pain and electrocardiographic evidence of myocardial infarction. Moreover, the distinction between ischaemic and non-ischaemic cardiomyopathy with SE may be impossible in patients presenting with severely dilated LV with very low EF and extensive and severe wall motion abnormalities. It should be emphasized that in such patients, only coronary angiography may be able to make the distinction between ischaemic and non-ischaemic aetiology. However, it has been shown using SE that patients with ischaemic cardiomyopathy are more likely to display >6 akinetic segments at peak dobutamine test, less improvement in regional wall motion at low-dose dobutamine, and more frequently a biphasic response (improvement at low-dose followed by subsequent deterioration at peak dose. In a study using stress long-axis function (long-axis M-mode and pulse wave tissue Doppler of the lateral, septal, and posterior walls), ischaemic cardiomyopathy was identified with greater sensitivity and specificity than with standard wall motion score index, particularly in the presence of a left bundle branch block.


Cardiac Resynchronization Therapy


Several studies have shown a direct relationship between the presence of inotropic contractile reserve as assessed by low-dose dobutamine SE and improvement in ventricular function after cardiac resynchronization therapy. During dobutamine infusion, an increase of LVEF by ≥7.5% identified responders to cardiac resynchronization therapy. Furthermore, patients are more likely to be non-responders to cardiac resynchronization therapy if the LV pacing lead is placed in the region of no contractile reserve (scarred myocardium). The presence of inotropic contractile reserve during dobutamine SE also has incremental but lower predictive power than echocardiographic mechanical dyssynchrony parameters such as septal flash ( Figure 12 ). The degree of response (improvement of EF during dobutamine infusion) correlates directly with the number of segments demonstrating inotropic contractile reserve.




Figure 12


Patient with idiopathic cardiomyopathy and limited exercise capacity. (A–C) Rest evaluation; (D–F) exercise echocardiography results. From rest to exercise, there is an increase in mitral regurgitation severity ( A and E ) and in left ventricular dyssynchrony (B–F) . (A and D) increase in effective regurgitant orifice area (EROA) during test. (B and F) Bulls-eye figures of longitudinal peak systolic strain values in the LV. From rest to exercise, global strain increases (−6.3% to −10.4%) indicating the presence of contractile reserve. During exercise, there is a significant dyssynchrony between the infero-lateral wall and the anteroseptum wall (regional strain color-coded changes from orange to blue). (C and F) M-Mode echocardiogram showing the occurrence of a septal flash (rapid inward motion of the septum within the isovolumic contraction period) at exercise. SPWD, septal posterior wall motion delay.


Response to Therapy


β-Blockers are an important treatment option for patients with HF. Data on the role of dobutamine SE for identifying responders to β-blocker therapy in HF patients are emerging. These studies have consistently shown that patients with inotropic contractile reserve not only tend to have improvement in global LV function and EF but also respond better to β-blockers. Hence, in patients with inotropic contractile reserve, β-blocker therapy results in improvement in both regional and global LV function compared with patients without inotropic contractile reserve. The improvement in regional and global LV functions is more pronounced in patients with non-ischaemic compared with ischaemic cardiomyopathy. Thus, in patients with non-ischaemic cardiomyopathy the presence of inotropic contractile reserve can predict who will respond to β-blocker therapy.




In patients with heart failure, SE is useful to identify the cause of dyspnoea and clinical deterioration and for individual risk stratification. SE also appears promising for guiding and monitoring response to treatment. The absence of contractile reserve is a strong determinant of outcome and a potential marker of response to cardiac resynchronization therapy.


Key Points




Native Valve Disease


The clinical indications for SE in native valve disease can be classified into three categories: severe valve disease without symptoms, non-severe valve disease with symptoms, and valve disease with low flow. In all cases, the purpose of the test is to identify the patients in need of intervention, namely those patients with severe valve disease and symptoms, LV systolic dysfunction, or other haemodynamic consequences ( Figure 13 ). Therefore, in severe valve disease without symptoms the main aim of the test is to elicit symptoms, which may not be otherwise appreciated because of sedentary lifestyle. Additionally, the haemodynamic consequences of exertion in the patient with severe valve disease, such as exercise-induced hypotension or arrhythmia, may be uncovered. In non-severe valve disease with symptoms, the main aim of the test is to question whether the valve disease is actually severe, re-grading the severity based on stress-induced changes or a potential dynamic component. In valve disease with low flow, the aim of the test is to determine whether the valve disease is severe based on flow-dependent changes in severity parameters with stress.


Apr 15, 2018 | Posted by in CARDIOLOGY | Comments Off on The Clinical Use of Stress Echocardiography in Non-Ischaemic Heart Disease: Recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography

Full access? Get Clinical Tree

Get Clinical Tree app for offline access